clofibrate has been researched along with Diabetes Mellitus, Type 1 in 6 studies
angiokapsul: contains clofibrate & insoitolnicotinate
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jahr, H | 1 |
| Kruschel, B | 1 |
| Walter, BM | 1 |
| Kohnert, KD | 1 |
| Belousova, LV | 1 |
| Zannino, L | 1 |
| Salvadori, G | 1 |
| Kissebah, AH | 1 |
| Rumpf, KW | 1 |
| Quellhrost, E | 1 |
| Scheler, F | 1 |
| Sońta-Jakimczyk, D | 1 |
| Otto-Buczkowska, E | 1 |
1 review available for clofibrate and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
[Platelet aggregation inhibitors. Their possible use in pediatric pathology].
Topics: Age Factors; Anti-Inflammatory Agents; Aspirin; Child; Clofibrate; Dextrans; Diabetes Mellitus, Type | 1979 |
5 other studies available for clofibrate and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Complement-mediated cytotoxic effects of islet cell surface antibodies: factors influencing the sensitivity of the target cells.
Topics: Animals; Clofibrate; Complement System Proteins; Cytotoxicity, Immunologic; Dactinomycin; Diabetes M | 1984 |
[Hypolipemic effectiveness of using miskleron in diabetes mellitus in children and adolescents with lipodystrophies].
Topics: Adolescent; Child; Clofibrate; Diabetes Mellitus, Lipoatrophic; Diabetes Mellitus, Type 1; Drug Eval | 1980 |
Management of hyperlipidemia in diabetes.
Topics: Cholestyramine Resin; Clofibrate; Diabetes Complications; Diabetes Mellitus, Type 1; Humans; Hyperch | 1979 |
[Diabetic nephropathy, hypothyroidism and colfibrate-induced myopathy (author's transl)].
Topics: Adult; Clofibrate; Diabetes Complications; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabet | 1976 |
[Effect of clofibrate on the levels of total lipids, cholesterol and beta-lipoproteins in diabetic children].
Topics: Adolescent; Age Factors; Child; Cholesterol; Clofibrate; Diabetes Mellitus, Type 1; Humans; Lipids; | 1974 |